Andrew Weidhaas > Goodwin > Santa Monica, United States > Lawyer Profile
Goodwin Offices

520 Broadway Suite #500
Santa Monica
CA 90401
CALIFORNIA
United States
- Firm Profile
- Go to...
Andrew Weidhaas

Position
Partner
Career
AJ Weidhaas is a partner in and former Co-Chair of Goodwin’s Private Equity group, and previously served as chair of the firm’s Santa Monica office. AJ serves on the firm’s Allocations Committee and has previously served on its Executive Committee and as chair of the New York Business Law department. He specializes in private equity and M&A transactions, including growth equity investments, leveraged buyouts and leveraged recapitalizations, going private transactions, SPACs and deSPACS. AJ’s experience ranges from the representation of growth companies in financings and buyouts in the middle market through later stage growth equity investments and LBOs and the representation of strategics in private and public M&A. His industry expertise includes technology, healthcare, consumer products, defense, real estate and financial services.
AJ’s clients include private equity sponsors Behrman Capital, Bregal Sagemount, Great Hill Partners, company clients KIND Snacks, Hyperice, Vertellus Manufacturing and MiraDx, and a number of Fortune 50 financial institutions in M&A and financing transactions.
Education
JD, 1993 Stanford Law School (with distinction) / BA, 1990 Yale University (magna cum laude, with distinction)
Top Tier Firm Rankings
- Industry focus > Cannabis
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Dispute resolution > E-discovery
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Intellectual property > Patents: litigation (full coverage)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > Shareholder activism
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- International trade and national security > CFIUS
- Finance > Commercial lending
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade and national security > Customs, export controls and economic sanctions
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Intellectual property > Patents: litigation (International Trade Commission)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Healthcare > Service providers
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Real estate > Real estate finance
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Finance > Financial services regulation